| Literature DB >> 30781503 |
Nijiati Abulizi1, Candice Quin2, Kirsty Brown3, Yee Kwan Chan4, Sandeep K Gill5, Deanna L Gibson6,7.
Abstract
The dynamics of the tripartite relationship between the host, gut bacteria and diet in the gut is relatively unknown. An imbalance between harmful and protective gut bacteria, termed dysbiosis, has been linked to many diseases and has most often been attributed to high-fat dietary intake. However, we recently clarified that the type of fat, not calories, were important in the development of murine colitis. To further understand the host-microbe dynamic in response to dietary lipids, we fed mice isocaloric high-fat diets containing either milk fat, corn oil or olive oil and performed 16S rRNA gene sequencing of the colon microbiome and mass spectrometry-based relative quantification of the colonic metaproteome. The corn oil diet, rich in omega-6 polyunsaturated fatty acids, increased the potential for pathobiont survival and invasion in an inflamed, oxidized and damaged gut while saturated fatty acids promoted compensatory inflammatory responses involved in tissue healing. We conclude that various lipids uniquely alter the host-microbe interaction in the gut. While high-fat consumption has a distinct impact on the gut microbiota, the type of fatty acids alters the relative microbial abundances and predicted functions. These results support that the type of fat are key to understanding the biological effects of high-fat diets on gut health.Entities:
Keywords: 16S rRNA gene amplicon sequencing; Host-microbe interactions; dietary lipids; gut microbiome; monounsaturated fatty acids; polyunsaturated fatty acids; proteome; saturated fatty acids; short-chain fatty acid metabolism
Mesh:
Substances:
Year: 2019 PMID: 30781503 PMCID: PMC6412740 DOI: 10.3390/nu11020418
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1The effect of lipid diets on the diversity of the gut microbiota. (A) Alpha diversity of colonic microbiota from mice fed high fats diets composed of low-fat chow (blue), milk fat (red), olive oil (purple) or corn oil (green). Observed species richness, Chao1, Shannon’s, and Simpson’s indexes are displayed. (B) PCoA plot of the weighted UniFrac distances of colonic microbial communities from mice fed high-fat diets composed of milk fat, olive oil, corn oil or low-fat chow. The first two principal components from the PCoA are plotted. (C) Statistical summary (p-values after Benjamini–Hochberg adjustment for multiple comparisons) of all alpha and beta diversity measures.
Figure 2The effect of lipid diets on the gut microbial taxa. (A) Comparison of the log abundance of the Firmicutes to Bacteroidetes ratio among experimental diet groups in the colon. The y-axis of the box plot indicates the log of the abundance of the Firmicutes divided by the abundance of Bacteroidetes. The low-fat group had a significantly lower Firmicutes to Bacteroidetes ratio than all the high-fat diets. Within the high-fat diets, olive oil had a significantly lower ratio of Firmicutes to Bacteroidetes than the milk fat group. (B) Relative abundances of Gram-positive and Gram-negative bacteria in the diet groups show a significantly lower abundance of gram positive bacteria and a corresponding higher abundance of gram negative bacteria in the low-fat dietary group. (C) Relative abundances of aerobic, anaerobic and facultatively anaerobic bacteria in the diet groups show significantly lower facultative anaerobic bacteria in the olive oil group compared to the milk fat and low-fat group. An asterisk above a single column indicates P < 0.05 for that group compared to every other group. An asterisk with a line connecting two groups indicates P < 0.05 between the two groups. (D) Differentially abundant microbial clades in the colon microbiota from mice fed high-fat diets composed of anhydrous milk fat, olive oil, corn oil or a low-fat normal chow. Cladogram represents taxonomic representation of statistically and biologically consistent differences among lipid diet groups. Significant differences are represented in the color of the most abundant class. Yellow circles represent non-significant microbial clades. The all-to-all version of LEfSe was used with Kruskal–Wallis test (P < 0.05). LDA score threshold was set at default value 2.
Figure 3The effect of lipid diets on predicted microbial functions. Statistically and biologically differentially abundant pathways amongst the four dietary group shown as a histogram of the LDA scores. The length of the bars represents a log10 transformed LDA score set to a threshold value of 2. The one-to-all version of LEfSe was used with Kruskal–Wallis test (P < 0.05).
Figure 4Predicted bacterial virulence traits and quantified secondary metabolites. Virulence traits such as (A) the relative abundance of bacteria which contain mobile elements and (B) the relative abundance of bacteria which are able to form biofilms are displayed for each diet group. (C) The effect of lipid diets on short-chain fatty acid production. Short-chain fatty acid analysis performed via gas chromatography on cecal samples from mice fed high-fat diets composed of milk fat, olive oil, corn oil or a low-fat chow. Acetic, propionic, and butyric acid are expressed as mass % of total cecal tissue sample. Values are expressed as mean +/− SEM (n = 8–12). An asterisk above a single column indicates P < 0.05 for that group compared to every other dietary group. An asterisk with a line connecting two groups indicates P < 0.05 between the two groups.
Figure 5Effects of lipid diets on the gut proteome shown by the Ingenuity pathway comparative analysis. (A) Heatmap visualization of metabolites detected in each dietary group. Orange color indicates a higher activation score, whereas blue color indicates a lower activation score. Ingenuity pathway analysis (IPA) identified many upstream regulators predicted to be active based on the gene expression profile including: (B) bleeding in the high-fat corn oil and (C) low-fat chow groups, (D) contractility of muscles in the corn oil group and (E) tumorigenesis of tissue in the olive oil group. Faded colors represent less of an effect.
Mucosal proteins contributing to IPA pathways and networks.
| Pathway | Symbol | Gene Name | Low Fat | Milk Fat | Olive Oil | Corn Oil |
|---|---|---|---|---|---|---|
|
| ||||||
| Death Receptor | ACIN1 | apoptotic chromatin condensation inducer 1 | 0.4 | −0.2 | 0 | −0.3 |
| signaling | CYCS | cytochrome c, somatic | 0.7 | 0.3 | −0.2 | −0.2 |
| HSPB1 | heat shock protein family B (small) member 1 | −0.5 | 0.5 | 0.1 | −0.2 | |
| LMNA | lamin A/C | 0.6 | −0.2 | −0.1 | −0.4 | |
| SPTAN1 | spectrin alpha, non-erythrocytic 1 | 0.6 | −0.1 | −0.1 | −0.2 | |
| Apoptosis | ACIN1 | apoptotic chromatin condensation inducer 1 | 0.4 | −0.2 | 0 | −0.3 |
| CAPN1 | calpain 1 | 0.8 | 0 | −0.1 | −0.1 | |
| CYCS | cytochrome c, somatic | 0.7 | 0.3 | −0.2 | −0.2 | |
| LMNA | lamin A/C | 0.6 | −0.2 | −0.1 | −0.4 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| SPTAN1 | spectrin alpha, non-erythrocytic 1 | 0.6 | −0.1 | −0.1 | −0.2 | |
|
|
| − |
|
|
| |
| tRNA charging | EPRS | glutamyl-prolyl-tRNA synthetase | 0.8 | −0.1 | −0.2 | 0 |
| FARSB | phenylalanyl-tRNA synthetase beta subunit | 0.7 | 0 | −0.2 | −0.1 | |
| KARS | lysyl-tRNA synthetase | 0.8 | −0.2 | −0.3 | −0.2 | |
| NARS | asparaginyl-tRNA synthetase | 0.9 | −0.3 | −0.5 | −0.4 | |
| RARS | arginyl-tRNA synthetase | 0.7 | −0.1 | −0.2 | 0 | |
| TARS | threonyl-tRNA synthetase | 0.8 | 0 | −0.2 | −0.1 | |
| VARS | valyl-tRNA synthetase | 0.4 | 0 | −0.1 | −0.2 | |
| YARS | tyrosyl-tRNA synthetase | 0.5 | −0.4 | −0.3 | −0.2 | |
| PPARa/RXRa | ACOX1 | acyl-CoA oxidase 1 | 0.5 | 0 | −0.3 | −0.4 |
| Activation | APOA1 | apolipoprotein A1 | −0.7 | 0.2 | −0.1 | 0.5 |
| CYP2C18 | cytochrome P450 family 2 subfamily C member 18 | 0.3 | −0.4 | 0.4 | −1.7 | |
| FASN | fatty acid synthase | 0 | 0 | 0 | 0.4 | |
| GPD1 | glycerol-3-phosphate dehydrogenase 1 | 1.3 | −0.6 | −0.4 | −0.3 | |
| HSP90B1 | heat shock protein 90 beta family member 1 | 0.2 | −0.4 | −0.3 | −0.1 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| PDIA3 | protein disulfide isomerase family A member 3 | −0.5 | 0 | 0 | 0.1 | |
|
| ||||||
| Glycolysis I | ALDOB | aldolase, fructose-bisphosphate B | 1.4 | −0.5 | −0.6 | −0.5 |
| ENO1 | enolase 1 | −0.5 | 0.2 | 0.1 | 0.3 | |
| FBP2 | fructose-bisphosphatase 2 | 0.2 | −0.2 | −0.2 | 0.1 | |
| TPI1 | triosephosphate isomerase 1 | −0.6 | 0 | 0 | 0.4 | |
| Oxidative | ATP5F1B | ATP synthase F1 subunit beta | −0.8 | 0.2 | 0 | 0.5 |
| phosphorylation | ATP5PB | ATP synthase peripheral stalk-membrane subunit b | 0.6 | −0.1 | −0.1 | −0.3 |
| ATP5PO | ATP synthase peripheral stalk subunit OSCP | −0.7 | 0.1 | 0.1 | 0.4 | |
| COX5A | cytochrome c oxidase subunit 5A | −0.9 | 0.3 | 0.2 | 0.6 | |
| CYCS | cytochrome c, somatic | 0.7 | 0.3 | −0.2 | −0.2 | |
| NDUFA9 | NADH:ubiquinone oxidoreductase subunit A9 | 0.8 | 0.2 | 0.2 | −0.1 | |
| NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | −0.4 | −0.2 | 0 | 0.4 | |
| NDUFS2 | NADH:ubiquinone oxidoreductase core subunit S2 | 0.6 | 0 | 0 | −0.1 | |
| NDUFS3 | NADH:ubiquinone oxidoreductase core subunit S3 | −0.8 | 0.1 | 0.1 | 0.3 | |
| NDUFV2 | NADH:ubiquinone oxidoreductase core subunit V2 | −0.3 | −0.1 | −0.1 | 0.3 | |
| UQCRB | ubiquinol-cytochrome c reductase binding protein | 0.2 | −0.3 | −0.3 | 0 | |
| UQCRC2 | ubiquinol-cytochrome c reductase core protein 2 | 0.3 | −0.1 | −0.1 | 0.1 | |
| NRF2-mediated | CBR1 | carbonyl reductase 1 | −0.4 | 0.1 | 0.1 | 0.2 |
| oxidative stress | CCT7 | chaperonin containing TCP1 subunit 7 | 0.5 | −0.2 | −0.2 | −0.3 |
| response | DNAJB11 | DnaJ heat shock protein family (Hsp40) member B11 | 0.7 | −0.2 | −0.4 | −0.5 |
| FTH1 | ferritin heavy chain 1 | −0.4 | 0.3 | 0 | 0.1 | |
| FTL | ferritin light chain | −0.2 | 0.2 | 0.2 | 0.3 | |
| GSR | glutathione-disulfide reductase | 0.6 | −0.1 | −0.2 | 0.1 | |
| GSTM3 | glutathione S-transferase mu 3 | 1.2 | 0.3 | 0.4 | 0.3 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| SOD1 | superoxide dismutase 1 | 0.6 | −0.1 | −0.2 | 0.2 | |
| USP14 | ubiquitin specific peptidase 14 | 0.6 | −0.2 | −0.2 | −0.1 | |
|
|
|
| − |
|
| |
|
|
|
|
|
|
| |
| Glutathione-mediated | ANPEP | alanyl aminopeptidase, membrane | 1.8 | −1.1 | −0.8 | −0.8 |
| detoxification | GGH | gamma-glutamyl hydrolase | 0.6 | 0.2 | −0.1 | 0.6 |
| Gsta4 | glutathione S-transferase, alpha 4 | 0.4 | 0 | 0 | −0.5 | |
| GSTM3 | glutathione S-transferase mu 3 | 1.2 | 0.3 | 0.4 | 0.3 | |
| GSTZ1 | glutathione S-transferase zeta 1 | −0.3 | −0.1 | 0.1 | 0.5 | |
| ILK signaling | ACTN1 | actinin alpha 1 | 0.3 | 0.1 | 0.1 | −0.3 |
| ACTN4 | actinin alpha 4 | 0.6 | −0.3 | −0.3 | −0.2 | |
| DSP | desmoplakin | 0.6 | −0.1 | 0 | −0.3 | |
| FLNA | filamin A | 0.4 | 0.2 | 0.3 | −0.4 | |
| FLNC | filamin C | 0.7 | 0.1 | 0.1 | −0.6 | |
| FN1 | fibronectin 1 | 0.7 | −0.1 | 0.1 | −0.8 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| MYH9 | myosin heavy chain 9 | 0.6 | −0.2 | −0.2 | −0.2 | |
| MYH11 | myosin heavy chain 11 | 0.7 | 0.2 | 0.4 | −0.6 | |
| MYH14 | myosin heavy chain 14 | 0.5 | −0.1 | −0.1 | −0.2 | |
| MYL9 | myosin light chain 9 | −0.5 | 0.4 | 0.6 | −0.2 | |
| PPP2R1A | protein phosphatase 2 scaffold subunit Alpha | −0.5 | 0.1 | 0.2 | 0.5 | |
| VCL | vinculin | 0.6 | −0.1 | 0.1 | −0.4 | |
| Epithelial integrity |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| VEGF signaling | ACTN1 | actinin alpha 1 | 0.3 | 0.1 | 0.1 | −0.3 |
| ACTN4 | actinin alpha 4 | 0.6 | −0.3 | −0.3 | −0.2 | |
| EIF2S3 | eukaryotic translation initiation factor 2 subunit γ | 0.4 | −0.1 | −0.1 | −0.2 | |
| ELAVL1 | ELAV like RNA binding protein 1 | 0.7 | −0.1 | −0.1 | −0.1 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| VCL | vinculin | 0.6 | −0.1 | 0.1 | −0.4 | |
| Bleeding network | APOE | apolipoprotein E | −0.7 | 0.2 | −0.1 | 0.5 |
| CNN1 | cluster of calponin-1 | −0.1 | 0.5 | 0.5 | −0.2 | |
| FLNA | filamin-a | 0.4 | 0.2 | 0.3 | −0.4 | |
| MYH9 | cluster of myosin-9 | 0.6 | −0.2 | −0.2 | −0.2 | |
| PLEC | cluster of plectin | 0.4 | −0.1 | 0 | −0.5 | |
| IL1RN | interleukin-1 receptor antagonist protein | −1 | 0.4 | −0.1 | 0.7 | |
| Contractility of muscle network | ATP2A2 | sarcoplasmic/endoplasmic reticulum calcium ATPase | 0.5 | −0.2 | −0.1 | −0.4 |
| CKM | cluster of creatine kinase M-type | −0.3 | 0.2 | 0.3 | −0.3 | |
| DES | cluster of desmin | 0.6 | 0.4 | 0.3 | −0.5 | |
| MYH11 | cluster of myosin-11 | 0.7 | 0.2 | 0.4 | −0.6 | |
| MYH14 | myosin-14 | 0.5 | −0.1 | −0.1 | −0.2 | |
| VCL | vinculin | 0.6 | −0.1 | 0.1 | −0.4 | |
|
| ||||||
| Acute Phase Response | APOA1 | apolipoprotein A1 | −0.7 | 0.2 | −0.1 | 0.5 |
| C3 | complement C3 | 0.4 | −0.1 | −0.8 | −0.7 | |
| FN1 | fibronectin 1 | 0.7 | −0.1 | 0.1 | −0.8 | |
| FTL | ferritin light chain | −0.2 | 0.2 | 0.2 | 0.3 | |
| HP | haptoglobin | 0.8 | 0.2 | −1.6 | −1.3 | |
| IL1RN | interleukin 1 receptor antagonist | −1 | 0.4 | −0.1 | 0.7 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| SERPINA3 | serpin family A member 3 | −0.6 | 0.6 | −1.4 | −1.1 | |
|
|
|
|
|
|
| |
| Sirtuin signaling | ADAM10 | ADAM metallopeptidase domain 10 | 0.4 | −0.1 | −0.2 | 0 |
| APEX1 | apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.7 | −0.1 | −0.2 | −0.3 | |
| ATP5F1B | ATP synthase F1 subunit beta | −0.8 | 0.2 | 0 | 0.5 | |
| ATP5PB | ATP synthase peripheral stalk-membrane subunit b | 0.6 | −0.1 | −0.1 | −0.3 | |
| CPS1 | carbamoyl-phosphate synthase 1 | 2.3 | −2 | −1.3 | −1.9 | |
| H1F0 | H1 histone family member 0 | −0.5 | 1.2 | 0.4 | −0.6 | |
| Hist1h1e | histone cluster 1, H1e | 0.3 | 1.1 | 0.1 | −0.6 | |
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 | −0.4 | 0 | −0.2 | −1.5 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| NAMPT | nicotinamide phosphoribosyltransferase | 0.6 | −0.1 | −0.2 | −0.3 | |
| NDUFA9 | NADH:ubiquinone oxidoreductase subunit A9 | 0.8 | 0.2 | 0.2 | −0.1 | |
| NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | −0.4 | −0.2 | 0 | 0.4 | |
| NDUFS2 | NADH:ubiquinone oxidoreductase core subunit S2 | 0.6 | 0 | 0 | −0.1 | |
| NDUFS3 | NADH:ubiquinone oxidoreductase core subunit S3 | −0.8 | 0.1 | 0.1 | 0.3 | |
| NDUFV2 | NADH:ubiquinone oxidoreductase core subunit V2 | −0.3 | −0.1 | −0.1 | 0.3 | |
| PDHA1 | pyruvate dehydrogenase E1 alpha 1 subunit | −0.3 | 0 | 0 | 0.1 | |
| SF3A1 | splicing factor 3a subunit 1 | 0.7 | 0 | 0.1 | −0.1 | |
| SLC25A5 | solute carrier family 25 member 5 | 0.9 | 0 | 0 | −0.2 | |
| SOD1 | superoxide dismutase 1 | 0.6 | −0.1 | −0.2 | 0.2 | |
| TIMM13 | translocase of inner mitochondrial membrane 13 | −0.2 | 0 | 0 | 0.3 | |
| UQCRC2 | ubiquinol-cytochrome c reductase core protein 2 | 0.3 | −0.1 | −0.1 | 0.1 | |
| VDAC1 | voltage dependent anion channel 1 | 0.1 | 0.3 | −0.1 | 0.2 | |
| Fatty acid B oxidation | ACAA2 | acetyl-CoA acyltransferase 2 | −0.4 | 0.1 | 0.2 | 0 |
| HADHA | hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | −0.1 | 0.2 | 0.1 | 0.2 | |
| HADHB | hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta | −0.4 | 0.2 | 0.1 | 0.1 | |
| IVD | isovaleryl-CoA dehydrogenase | −0.6 | −0.1 | 0 | 0.2 | |
|
| ||||||
| Actin cytoskeleton | ACTN1 | actinin alpha 1 | 0.3 | 0.1 | 0.1 | −0.3 |
| signaling | ACTN4 | actinin alpha 4 | 0.6 | −0.3 | −0.3 | −0.2 |
| ARPC5 | actin related protein 2/3 complex subunit 5 | −0.4 | 0.2 | 0 | 0.4 | |
| FLNA | filamin A | 0.4 | 0.2 | 0.3 | −0.4 | |
| FN1 | fibronectin 1 | 0.7 | −0.1 | 0.1 | −0.8 | |
| IQGAP2 | IQ motif containing GTPase activating protein 2 | 0.7 | 0 | −0.1 | −0.2 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.2 | 0 | −0.2 | −0.1 | |
| MYH9 | myosin heavy chain 9 | 0.6 | −0.2 | −0.2 | −0.2 | |
| MYH11 | myosin heavy chain 11 | 0.7 | 0.2 | 0.4 | −0.6 | |
| MYH14 | myosin heavy chain 14 | 0.5 | −0.1 | −0.1 | −0.2 | |
| MYL9 | myosin light chain 9 | −0.5 | 0.4 | 0.6 | −0.2 | |
| VCL | vinculin | 0.6 | −0.1 | 0.1 | −0.4 | |
|
|
| − |
|
| − | |
| Tumorigenesis of | ACOX1 | acyl-coenzyme A oxidase 1 | 0.5 | 0 | −0.3 | −0.4 |
| tissue network | APOA1 | apolipoprotein a-1 | −0.7 | 0.2 | −0.1 | 0.5 |
| ATP2A2 | sarcoplasmic/endoplasmic reticulum calcium ATPase2 | 0.5 | −0.2 | −0.1 | −0.4 | |
| C3 | complement C3 | 0.4 | −0.1 | −0.8 | −0.7 | |
| HP | hippocalcin-like protein 1 | 0.8 | −0.2 | −0.2 | 0.2 | |
| IL1RN | interleukin-1 receptor antagonist protein | −1 | 0.4 | −0.1 | 0.7 | |
| MTTP | microsomal triglyceride transfer protein large subunit | 2.4 | −2 | −1.7 | −2.1 | |
| PC | pyruvate carboxylase | −0.2 | 0.2 | 0.1 | 0.4 |
Displayed are the experimental log ratios. Compared to the pooled reference channel (value normalized to zero), positive values indicate an increased fold-change expression whereas negative values indicate a decreased fold-change expression Italicized proteins were not included in IPA pathway. NA indicates the protein did not reach the 0.006 threshold. All groups are compared to the pool which was set to zero. Abbreviations used: OSCP, oligomycin sensitivity conferral protein; VEGF, vascular endothelial growth factor.